Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2003241

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2003241

Poultry Diagnostics Market by Product Type (Consumable & Reagent, Instrument), Test Type (PCR, ELISA, Rapid Antigen Tests), Disease Type, Poultry Type (Broiler, Layer, Turkey, Duck & Geese), Sample Type (Swabs, Serum, Blood) - Global Forecast to 2031

PUBLISHED:
PAGES: 610 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The poultry diagnostics market is projected to grow from USD 0.18 billion in 2026 to USD 0.25 billion by 2031, at a CAGR of 7.1%. This growth is driven by several key factors that are shaping the future of poultry disease diagnostics, surveillance, and flock health management. The primary driver of the poultry diagnostics market is the rapid expansion of commercial poultry production worldwide and the increasing demand to control infectious disease outbreaks in large flocks.

Scope of the Report
Years Considered for the Study2024-2031
Base Year2025
Forecast Period2025-2031
Units ConsideredValue (USD billion)
SegmentsType, Form, Indication, Modality, Route of Administration, Application, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East, and Africa

As poultry farming becomes more intensive, businesses in animal husbandry are adopting early disease detection and regular health monitoring as essential strategies to prevent production losses and ensure the ongoing productivity of their flocks. Consequently, poultry farms, veterinary laboratories, and integrated poultry companies are increasingly using advanced diagnostic methods, such as PCR and ELISA, to quickly and accurately identify pathogens, including avian influenza, Newcastle disease, and infectious bronchitis.

Poultry Diagnostics Market - IMG1

Another significant factor driving demand is the heightened focus on biosafety, food security, and the control of regulated diseases throughout the global poultry supply chain. Governments, international organizations, and poultry farmers are enhancing their disease-tracking systems to prepare for major outbreaks that could result in substantial losses in meat and egg production and disrupt international trade. As a result, the use of diagnostics in poultry testing has become a common practice to facilitate safe access to production facilities and enable producers and veterinary authorities to implement timely containment measures while maintaining stable production levels.

Moreover, advancements in molecular diagnostics, automation, and mass testing capabilities have significantly improved the accuracy and efficiency of identifying poultry diseases. Innovations such as rapid PCR testing methods, robotic ELISA operations, portable diagnostic kits, and advanced sample processing are reducing response times and enabling large-scale testing of entire flocks. By leveraging these technological advancements, poultry producers and diagnostic laboratories can enhance their disease control strategies, ensuring optimal flock health monitoring and promoting ecological stability within modern poultry farming systems.

"By test type, the PCR-based diagnostics segment is projected to grow at the highest CAGR during the forecast period."

The PCR-based diagnostics segment is expected to experience the highest growth in the poultry diagnostics market due to its high sensitivity and specificity, as well as its ability to quickly detect pathogens. PCR technology can identify even trace amounts of viral or bacterial genetic material. This capability allows for the detection of poultry diseases, such as avian influenza, Newcastle disease, and infectious bronchitis, at the pre-symptomatic stage, providing a timely opportunity for intervention. Intervening early helps limit the spread and impact of epidemics, reducing production losses. Additionally, the increasing demand for rapid, large-scale testing and improved disease monitoring in intensive poultry production systems is driving the widespread adoption of PCR-based diagnostics on commercial farms and in veterinary diagnostic laboratories.

"By sample type, the swabs segment accounted for the largest market share in 2025."

In 2025, swabs led the poultry diagnostics market due to their ease of collection, non-invasive nature, and high reliability in detecting poultry pathogens. The two most common types of swab samples collected for diseases such as avian influenza, Newcastle disease, and infectious bronchitis are oropharyngeal and cloacal swabs. These swab samples are often used for disease surveillance and outbreak investigations. Swabs are the preferred sample type on poultry farms, in veterinary laboratories, and in surveillance programs because they are compatible with widely used diagnostic methods such as PCR and ELISA. Additionally, swabs facilitate sample collection from large flocks, making them ideal for large-scale testing and monitoring programs, which explains their extensive use in poultry disease diagnostics.

"The Asia Pacific region is expected to witness the highest growth rate during the forecast period."

The Asia Pacific region is experiencing the fastest growth in the poultry diagnostics market. This growth can be attributed to several factors, including the rapid increase in poultry production, higher consumption rates, and the expansion of disease surveillance in major poultry-producing countries such as China, India, and various Southeast Asian nations. The region has faced multiple outbreaks of avian influenza and Newcastle disease, highlighting the importance of early detection and regular flock monitoring. Additionally, improvements in veterinary infrastructure and the rise of government initiatives for disease control and food safety are enabling poultry farms and veterinary laboratories in the region to adopt advanced diagnostic technologies more swiftly.

Breakdown of supply-side primary interviews:

By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)

By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)

By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:

By End User: Veterinary Diagnostic Laboratories (45%), Integrated Poultry Producers (24%), Government & Reference Laboratories (14%), Academic & Research Institutions (10%), and Other Specialized Laboratories (7%)

By Designation: Heads/Directors of Veterinary Diagnostic Laboratories (47%), Poultry Veterinarians/Technical Services Managers (22%), Animal Health Surveillance Officers (15%), and Others (16%)

By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)

Research Coverage

The market study covers the poultry diagnostics market in various segments. It aims to estimate the market size and growth potential by product type, test type, disease type, poultry type, sample type, end user, and region. The study also includes an in-depth competitive analysis of the market's key players, along with their company profiles, key observations on their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:

  • Analysis of key drivers (rising incidence of transboundary & endemic diseases and growth in commercial & industrial poultry production), restraints (high cost of advanced molecular testing platforms and limited diagnostic infrastructure in developing regions), opportunities (geographic expansion in emerging poultry markets and development of rapid point-of-care (POC) tests), and challenges (rapid mutation and strain variability of viral pathogens and limited awareness among small & backyard farmers) influencing the growth of the poultry diagnostics market.
  • Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the poultry diagnostics market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of poultry diagnostic products across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the poultry diagnostics market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the poultry diagnostics market.
Show more
Product Code: MD 5241

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 MARKET STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN POULTRY DIAGNOSTICS MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 POULTRY DIAGNOSTICS MARKET OVERVIEW
  • 3.2 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE & COUNTRY (2025)
  • 3.3 POULTRY DIAGNOSTICS MARKET: REGIONAL MIX
  • 3.4 POULTRY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 3.5 POULTRY DIAGNOSTICS MARKET: DEVELOPED VS. EMERGING ECONOMIES

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising incidence of transboundary and endemic diseases
      • 4.2.1.2 Growth in commercial and industrial poultry production
      • 4.2.1.3 Shift toward preventive flock health management
      • 4.2.1.4 Technological advancements in molecular diagnostics, multiplex assays, and rapid testing platforms
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 High cost of advanced molecular diagnostic platforms and automated systems
      • 4.2.2.2 Limited diagnostic infrastructure in developing regions
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Geographic expansion in emerging poultry markets
      • 4.2.3.2 Expansion of rapid point-of-care and portable on-farm diagnostic solutions
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Rapid mutation and strain variability of viral pathogens
      • 4.2.4.2 Limited awareness among small & backyard farmers
  • 4.3 UNMET NEEDS & WHITE SPACES
    • 4.3.1 UNMET NEEDS IN POULTRY DIAGNOSTICS MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
    • 4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 THREAT OF NEW ENTRANTS
    • 5.1.2 THREAT OF SUBSTITUTES
    • 5.1.3 BARGAINING POWER OF SUPPLIERS
    • 5.1.4 BARGAINING POWER OF BUYERS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS & FORECAST
    • 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
    • 5.2.4 TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY
  • 5.3 SUPPLY CHAIN ANALYSIS
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 PRICING ANALYSIS
    • 5.6.1 AVERAGE SELLING PRICE TREND OF POULTRY DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023-2025
    • 5.6.2 AVERAGE SELLING PRICE TREND OF POULTRY DIAGNOSTIC PRODUCTS, BY REGION, 2023-2025
      • 5.6.2.1 Average selling price trend of ELISA kits & reagents, by region, 2023-2025
      • 5.6.2.2 Average selling price trend of PCR reagents & kits, by region, 2023-2025
      • 5.6.2.3 Average selling price trend of sample preparation & extraction kits, by region, 2023-2025
      • 5.6.2.4 Average selling price trend of controls & laboratory consumables, by region, 2023-2025
      • 5.6.2.5 Average selling price trend of PCR instruments, by region, 2023-2025
      • 5.6.2.6 Average selling price trend of ELISA readers & washers, by region, 2023-2025
      • 5.6.2.7 Average selling price trend of nucleic acid extraction systems, by region, 2023-2025
  • 5.7 TRADE ANALYSIS
    • 5.7.1 TRADE DATA FOR HS CODE 3822
      • 5.7.1.1 Import data for HS Code 3822
      • 5.7.1.2 Export data for HS Code 3822
  • 5.8 KEY CONFERENCES & EVENTS, 2026-2027
  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.10 INVESTMENT & FUNDING SCENARIO
  • 5.11 SUCCESS STORIES & REAL-WORLD APPLICATIONS
    • 5.11.1 AI-POWERED POULTRY DISEASE DIAGNOSTICS FOR COCCIDIOSIS & SALMONELLA DETECTION
    • 5.11.2 MOLECULAR DETECTION AND CHARACTERIZATION OF AVIAN PATHOGENS USING MULTIPLEX PCR
    • 5.11.3 MULTIPLEX PCR DETECTION OF RESPIRATORY PATHOGENS IN COMMERCIAL POULTRY FLOCKS
  • 5.12 IMPACT OF 2025 US TARIFFS ON POULTRY DIAGNOSTICS MARKET
    • 5.12.1 INTRODUCTION
    • 5.12.2 KEY TARIFF RATES
    • 5.12.3 PRICE IMPACT ANALYSIS
    • 5.12.4 IMPACT ON COUNTRY/REGION
    • 5.12.5 IMPACT ON END-USE INDUSTRIES
      • 5.12.5.1 Veterinary diagnostic laboratories
      • 5.12.5.2 Integrated poultry producers
      • 5.12.5.3 Government & reference laboratories
      • 5.12.5.4 Academic & research institutions
      • 5.12.5.5 Other specialized laboratories

6 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, AND DIGITAL & AI ADOPTION

  • 6.1 TECHNOLOGY ANALYSIS
    • 6.1.1 KEY EMERGING TECHNOLOGIES
      • 6.1.1.1 CRISPR-based molecular diagnostics
      • 6.1.1.2 Isothermal amplification and paper-based LAMP
    • 6.1.2 COMPLEMENTARY TECHNOLOGIES
      • 6.1.2.1 Environmental & wastewater surveillance
      • 6.1.2.2 Microfluidic sensors
    • 6.1.3 ADJACENT TECHNOLOGIES
      • 6.1.3.1 AI & machine learning
      • 6.1.3.2 Multiplex PCR panels
  • 6.2 TECHNOLOGY/PRODUCT ROADMAP
    • 6.2.1 NEAR TERM (2025-2027)
    • 6.2.2 MID TERM (2028-2030)
    • 6.2.3 LONG TERM (2030+)
  • 6.3 PATENT ANALYSIS
    • 6.3.1 PATENT PUBLICATION TRENDS FOR POULTRY DIAGNOSTICS
    • 6.3.2 JURISDICTION & TOP APPLICANT ANALYSIS
  • 6.4 FUTURE APPLICATIONS
    • 6.4.1 PRECISION FLOCK-LEVEL DISEASE PREDICTION
    • 6.4.2 MINI FULLY INTEGRATED ON-FARM MOLECULAR TESTING PLATFORMS
    • 6.4.3 CONTINUOUS ENVIRONMENTAL & WASTEWATER MONITORING SYSTEMS
    • 6.4.4 MULTIPLEX & SYNDROMIC POULTRY DIAGNOSTIC PANELS
    • 6.4.5 SMART BIOSENSOR-ENABLED REAL-TIME HEALTH MONITORING
  • 6.5 IMPACT OF AI/GENERATIVE AI ON POULTRY DIAGNOSTICS MARKET
    • 6.5.1 INTRODUCTION
    • 6.5.2 MARKET POTENTIAL IN POULTRY DIAGNOSTIC ECOSYSTEM
    • 6.5.3 AI USE CASES
    • 6.5.4 KEY COMPANIES IMPLEMENTING AI IN POULTRY DIAGNOSTICS MARKET

7 SUSTAINABILITY & REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS & COMPLIANCE
    • 7.1.1 REGULATORY ANALYSIS
    • 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.3 INDUSTRY STANDARDS
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR POULTRY DIAGNOSTIC PRODUCTS
    • 7.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
    • 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 KEY STAKEHOLDERS & BUYING CRITERIA
    • 8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.1.2 BUYING CRITERIA
  • 8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
    • 8.2.1 DECISION-MAKING PROCESS
    • 8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES
    • 8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
    • 8.2.4 MARKET PROFITABILITY

9 POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE

  • 9.1 INTRODUCTION
  • 9.2 CONSUMABLES & REAGENTS
    • 9.2.1 ELISA KITS & REAGENTS
      • 9.2.1.1 Large-scale serological surveillance and vaccination monitoring to sustain demand
      • 9.2.1.2 Global volume analysis of ELISA kits & reagents, 2024-2031 (thousand units)
    • 9.2.2 PCR KITS & REAGENTS
      • 9.2.2.1 Rising adoption of molecular diagnostics to accelerate demand
      • 9.2.2.2 Global volume analysis of PCR kits & reagents, 2024-2031 (thousand units)
    • 9.2.3 SAMPLE PREPARATION & EXTRACTION KITS
      • 9.2.3.1 Increasing use of molecular testing to fuel market growth
      • 9.2.3.2 Global volume analysis of sample preparation & extraction kits, 2024-2031 (thousand units)
    • 9.2.4 CONTROLS & LABORATORY CONSUMABLES
      • 9.2.4.1 Expanding diagnostic test volumes to drive consistent demand
      • 9.2.4.2 Global volume analysis of controls & laboratory consumables, 2024-2031 (thousand units)
  • 9.3 INSTRUMENTS
    • 9.3.1 PCR INSTRUMENTS
      • 9.3.1.1 Growing need for rapid and high-sensitivity pathogen detection to boost market
      • 9.3.1.2 Global volume analysis of PCR instruments, 2024-2031 (thousand units)
    • 9.3.2 ELISA READERS & WASHERS
      • 9.3.2.1 High-throughput serological testing to support continued use of ELISA readers
      • 9.3.2.2 Global volume analysis of ELISA readers & washers, 2024-2031 (thousand units)
    • 9.3.3 NUCLEIC ACID EXTRACTION SYSTEMS
      • 9.3.3.1 Rising molecular testing workflows to drive adoption
      • 9.3.3.2 Global volume analysis of nucleic acid extraction systems, 2024-2031 (thousand units)
    • 9.3.4 OTHER LABORATORY AUTOMATION INSTRUMENTS
      • 9.3.4.1 Global volume analysis of other laboratory automation instruments, 2024-2031 (thousand units)

10 POULTRY DIAGNOSTICS MARKET, BY TEST TYPE

  • 10.1 INTRODUCTION
  • 10.2 PCR-BASED DIAGNOSTICS
    • 10.2.1 AVIAN INFLUENZA PCR PANELS
      • 10.2.1.1 Global surveillance programs and outbreak monitoring to boost demand
      • 10.2.1.2 Global volume analysis of avian influenza PCR panels, 2024-2031 (thousand tests)
      • 10.2.1.3 Global volume analysis of avian influenza PCR panels, 2024-2031 (thousand animals)
    • 10.2.2 NEWCASTLE DISEASE PCR PANELS
      • 10.2.2.1 High transmissibility of Newcastle disease to increase reliance on molecular PCR detection
      • 10.2.2.2 Global volume analysis of Newcastle disease PCR panels, 2024-2031 (thousand tests)
      • 10.2.2.3 Global volume analysis of Newcastle disease PCR panels, 2024-2031 (thousand animals)
    • 10.2.3 ENDEMIC VIRAL PCR PANELS
      • 10.2.3.1 Routine flock health monitoring to accelerate use of multiplex endemic viral PCR panels
      • 10.2.3.2 Global volume analysis of endemic viral PCR panels, 2024-2031 (thousand tests)
      • 10.2.3.3 Global volume analysis of endemic viral PCR panels, 2024-2031 (thousand animals)
    • 10.2.4 MYCOPLASMA PCR PANELS
      • 10.2.4.1 Need for early identification of mycoplasma infections to drive adoption
      • 10.2.4.2 Global volume analysis of Mycoplasma PCR panels, 2024-2031 (thousand tests)
      • 10.2.4.3 Global volume analysis of Mycoplasma PCR panels, 2024-2031 (thousand animals)
    • 10.2.5 BACTERIAL PCR PANELS
      • 10.2.5.1 Increasing focus on pathogen detection and food safety to support market growth
      • 10.2.5.2 Global volume analysis of bacterial PCR panels, 2024-2031 (thousand tests)
      • 10.2.5.3 Global volume analysis of bacterial PCR panels, 2024-2031 (thousand animals)
  • 10.3 ELISA-BASED DIAGNOSTICS
    • 10.3.1 ENDEMIC VIRAL ELISA TESTS
      • 10.3.1.1 Routine immunity monitoring in poultry flocks to drive demand
      • 10.3.1.2 Global volume analysis of endemic viral ELISA tests, 2024-2031 (thousand tests)
      • 10.3.1.3 Global volume analysis of endemic viral ELISA tests, 2024-2031 (thousand animals)
    • 10.3.2 AVIAN INFLUENZA ELISA TESTS
      • 10.3.2.1 Large-scale serological surveillance programs to support use of avian influenza ELISA assays
      • 10.3.2.2 Global volume analysis of avian influenza ELISA tests, 2024-2031 (thousand tests)
      • 10.3.2.3 Global volume analysis of avian influenza ELISA tests, 2024-2031 (thousand animals)
    • 10.3.3 NEWCASTLE DISEASE ELISA TESTS
      • 10.3.3.1 Vaccination monitoring and flock immunity assessment to fuel demand
      • 10.3.3.2 Global volume analysis of Newcastle disease ELISA tests, 2024-2031 (thousand tests)
      • 10.3.3.3 Global volume analysis of Newcastle disease ELISA tests, 2024-2031 (thousand animals)
    • 10.3.4 MYCOPLASMA ELISA TESTS
      • 10.3.4.1 Ongoing flock health surveillance to increase adoption of mycoplasma ELISA testing
      • 10.3.4.2 Global volume analysis of mycoplasma ELISA tests, 2024-2031 (thousand tests)
      • 10.3.4.3 Global volume analysis of mycoplasma ELISA tests, 2024-2031 (thousand animals)
    • 10.3.5 BACTERIAL ELISA TESTS
      • 10.3.5.1 Growing emphasis on bacterial disease control to support use of bacterial ELISA diagnostics
      • 10.3.5.2 Global volume analysis of bacterial ELISA tests, 2024-2031 (thousand tests)
      • 10.3.5.3 Global volume analysis of bacterial ELISA tests, 2024-2031 (thousand animals)
  • 10.4 OTHER DIAGNOSTIC TESTS

11 POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE

  • 11.1 INTRODUCTION
  • 11.2 AVIAN INFLUENZA
    • 11.2.1 GLOBAL SURVEILLANCE PROGRAMS AND FREQUENT HPAI OUTBREAKS TO DRIVE DEMAND
  • 11.3 NEWCASTLE DISEASE
    • 11.3.1 HIGH CONTAGIOUSNESS AND ONGOING OUTBREAK RISKS TO FUEL MARKET GROWTH
  • 11.4 INFECTIOUS BRONCHITIS
    • 11.4.1 EMERGENCE OF MULTIPLE IBV VARIANTS TO INCREASE DEMAND FOR DIAGNOSTICS
  • 11.5 AVIAN MYCOPLASMOSIS
    • 11.5.1 RISING FOCUS ON RESPIRATORY DISEASE CONTROL TO BOOST ADOPTION
  • 11.6 SALMONELLOSIS
    • 11.6.1 INCREASING FOOD SAFETY REGULATIONS AND SURVEILLANCE PROGRAMS TO BOOST MARKET GROWTH
  • 11.7 INFECTIOUS BURSAL DISEASE
    • 11.7.1 NEED TO MONITOR IMMUNOSUPPRESSIVE VIRAL INFECTIONS TO DRIVE DEMAND
  • 11.8 OTHER INFECTIOUS DISEASES

12 POULTRY DIAGNOSTICS MARKET, BY POULTRY TYPE

  • 12.1 INTRODUCTION
  • 12.2 PCR-BASED DIAGNOSTICS
    • 12.2.1 BROILERS
      • 12.2.1.1 High-density meat production systems to drive strong adoption of PCR testing
    • 12.2.2 LAYERS
      • 12.2.2.1 Need for rapid detection of diseases affecting egg production to support market growth
    • 12.2.3 BREEDERS
      • 12.2.3.1 Prevention of vertical pathogen transmission to drive extensive PCR surveillance
    • 12.2.4 TURKEYS
      • 12.2.4.1 Disease monitoring in commercial turkey production to support adoption
    • 12.2.5 DUCKS & GEESE
      • 12.2.5.1 Role of waterfowl in avian influenza surveillance to increase PCR testing
    • 12.2.6 OTHER POULTRY
  • 12.3 ELISA-BASED DIAGNOSTICS
    • 12.3.1 BROILERS
      • 12.3.1.1 Monitoring vaccine-induced immunity to drive ELISA-based serological testing
    • 12.3.2 LAYERS
      • 12.3.2.1 Long production cycles and egg yield monitoring to support market growth
    • 12.3.3 BREEDERS
      • 12.3.3.1 Routine antibody monitoring for disease-free breeding programs to drive ELISA testing
    • 12.3.4 TURKEYS
      • 12.3.4.1 Need for effective vaccination monitoring to support ELISA-based diagnostics
    • 12.3.5 DUCKS & GEESE
      • 12.3.5.1 Serological surveillance of waterfowl populations to boost market growth
    • 12.3.6 OTHER POULTRY
  • 12.4 OTHER DIAGNOSTIC TESTS
    • 12.4.1 BROILERS
      • 12.4.1.1 Rapid screening and confirmatory testing to require conventional diagnostics
    • 12.4.2 LAYERS
      • 12.4.2.1 Long-term flock monitoring to drive continued use of traditional diagnostic tests
    • 12.4.3 BREEDERS
      • 12.4.3.1 Established serological methods to support disease surveillance in breeder flocks
    • 12.4.4 TURKEYS
      • 12.4.4.1 Routine disease screening and pathogen identification to sustain use of conventional diagnostics
    • 12.4.5 DUCKS & GEESE
      • 12.4.5.1 Surveillance of waterfowl-associated pathogens to maintain use of traditional diagnostic methods
    • 12.4.6 OTHER POULTRY

13 POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE

  • 13.1 INTRODUCTION
  • 13.2 SWABS
    • 13.2.1 EASE OF COLLECTION AND SUITABILITY FOR MOLECULAR TESTING TO DRIVE WIDESPREAD USE OF SWAB SAMPLES
  • 13.3 SERUM/BLOOD
    • 13.3.1 GROWING FOCUS ON FLOCK IMMUNITY MONITORING AND VACCINATION ASSESSMENT TO SUPPORT DEMAND
  • 13.4 TISSUE SAMPLES
    • 13.4.1 NEED FOR CONFIRMATORY DIAGNOSIS AND DETAILED PATHOLOGICAL INVESTIGATION TO DRIVE MARKET GROWTH
  • 13.5 ENVIRONMENTAL & FECAL SAMPLES
    • 13.5.1 RISING EMPHASIS ON FARM-LEVEL SURVEILLANCE AND BIOSECURITY MONITORING TO BOOST ADOPTION

14 POULTRY DIAGNOSTICS MARKET, BY END USER

  • 14.1 INTRODUCTION
  • 14.2 VETERINARY DIAGNOSTIC LABORATORIES
    • 14.2.1 CENTRAL ROLE IN DISEASE SURVEILLANCE AND HIGH TESTING VOLUMES TO DRIVE DEMAND
  • 14.3 INTEGRATED POULTRY PRODUCERS
    • 14.3.1 GROWING VERTICAL INTEGRATION AND NEED FOR CONTINUOUS FLOCK MONITORING TO INCREASE DIAGNOSTIC ADOPTION
  • 14.4 GOVERNMENT & REFERENCE LABORATORIES
    • 14.4.1 NATIONAL DISEASE SURVEILLANCE PROGRAMS AND REGULATORY TESTING REQUIREMENTS TO BOOST MARKET GROWTH
  • 14.5 ACADEMIC & RESEARCH INSTITUTIONS
    • 14.5.1 RISING RESEARCH ON POULTRY PATHOGENS AND DIAGNOSTIC INNOVATION TO SUPPORT DEMAND
  • 14.6 OTHER SPECIALIZED LABORATORIES
    • 14.6.1 INCREASING OUTSOURCING OF ADVANCED TESTING SERVICES TO DRIVE DEMAND

15 POULTRY DIAGNOSTICS MARKET, BY REGION

  • 15.1 INTRODUCTION
  • 15.2 NORTH AMERICA
    • 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 15.2.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031
    • 15.2.3 NORTH AMERICA: VOLUME ANALYSIS, BY TEST TYPE, 2024-2031
    • 15.2.4 US
      • 15.2.4.1 Large-scale poultry production to drive demand for poultry diagnostic testing
    • 15.2.5 CANADA
      • 15.2.5.1 Strong biosecurity regulations and expanding poultry production to drive market
  • 15.3 EUROPE
    • 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 15.3.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031
    • 15.3.3 EUROPE: VOLUME ANALYSIS, BY TEST TYPE, 2024-2031
    • 15.3.4 GERMANY
      • 15.3.4.1 Germany to dominate European market during forecast period
    • 15.3.5 UK
      • 15.3.5.1 Robust disease surveillance programs to drive market growth
    • 15.3.6 FRANCE
      • 15.3.6.1 Frequent avian influenza outbreaks and large poultry production systems to fuels market growth
    • 15.3.7 ITALY
      • 15.3.7.1 Growing poultry production to support market growth
    • 15.3.8 SPAIN
      • 15.3.8.1 Expanding broiler production and increasing disease surveillance to drive market growth
    • 15.3.9 NETHERLANDS
      • 15.3.9.1 Advanced veterinary surveillance infrastructure to drive market growth
    • 15.3.10 POLAND
      • 15.3.10.1 Rapid expansion of poultry production and export-oriented farming to increase demand
    • 15.3.11 RUSSIA
      • 15.3.11.1 Expanding domestic poultry production to drive market growth
    • 15.3.12 REST OF EUROPE
  • 15.4 ASIA PACIFIC
    • 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 15.4.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031
    • 15.4.3 ASIA PACIFIC: VOLUME ANALYSIS, BY TEST TYPE, 2024-2031
    • 15.4.4 CHINA
      • 15.4.4.1 China to dominate APAC market during forecast period
    • 15.4.5 JAPAN
      • 15.4.5.1 Recurring avian influenza outbreaks to drive market
    • 15.4.6 INDIA
      • 15.4.6.1 Rapidly expanding poultry industry and increasing disease surveillance initiatives to boost market growth
    • 15.4.7 AUSTRALIA
      • 15.4.7.1 Strong biosecurity regulations and advanced poultry production systems to support market growth
    • 15.4.8 SOUTH KOREA
      • 15.4.8.1 Frequent avian influenza outbreaks and intensive poultry farming to boost market growth
    • 15.4.9 THAILAND
      • 15.4.9.1 Export-oriented poultry production to drive market
    • 15.4.10 NEW ZEALAND
      • 15.4.10.1 Strict biosecurity systems and preventive disease surveillance programs to support market growth
    • 15.4.11 INDONESIA
      • 15.4.11.1 Large poultry population to fuel market growth
    • 15.4.12 PHILIPPINES
      • 15.4.12.1 Expanding poultry production and rising disease monitoring efforts to drive adoption
    • 15.4.13 REST OF ASIA PACIFIC
  • 15.5 LATIN AMERICA
    • 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 15.5.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031
    • 15.5.3 LATIN AMERICA: VOLUME ANALYSIS, BY TEST TYPE, 2024-2031
    • 15.5.4 BRAZIL
      • 15.5.4.1 Large-scale poultry production and export-driven poultry industry to drive demand
    • 15.5.5 MEXICO
      • 15.5.5.1 Strong domestic poultry consumption to contribute to market growth
    • 15.5.6 ARGENTINA
      • 15.5.6.1 Expanding poultry production and increased disease monitoring to drive market
    • 15.5.7 REST OF LATIN AMERICA
  • 15.6 MIDDLE EAST & AFRICA
    • 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 15.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024-2031
    • 15.6.3 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY TEST TYPE, 2024-2031
    • 15.6.4 GCC COUNTRIES
      • 15.6.4.1 Kingdom of Saudi Arabia (KSA)
        • 15.6.4.1.1 Expanding domestic poultry production and national food security initiatives to boost growth
      • 15.6.4.2 United Arab Emirates (UAE)
        • 15.6.4.2.1 Increasing investments in poultry farming to fuel UAE's market growth
      • 15.6.4.3 Rest of GCC Countries
    • 15.6.5 REST OF MIDDLE EAST & AFRICA

16 COMPETITIVE LANDSCAPE

  • 16.1 OVERVIEW
  • 16.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 16.3 REVENUE ANALYSIS, 2021-2025
  • 16.4 MARKET SHARE ANALYSIS, 2025
    • 16.4.1 US MARKET SHARE ANALYSIS, 2025
    • 16.4.2 EUROPE MARKET SHARE ANALYSIS, 2025
    • 16.4.3 RANKING OF KEY MARKET PLAYERS
  • 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 16.5.1 STARS
    • 16.5.2 EMERGING LEADERS
    • 16.5.3 PERVASIVE PLAYERS
    • 16.5.4 PARTICIPANTS
    • 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 16.5.5.1 Company footprint
      • 16.5.5.2 Region footprint
      • 16.5.5.3 Product type footprint
      • 16.5.5.4 Test type footprint
      • 16.5.5.5 Disease type footprint
  • 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 16.6.1 PROGRESSIVE COMPANIES
    • 16.6.2 RESPONSIVE COMPANIES
    • 16.6.3 DYNAMIC COMPANIES
    • 16.6.4 STARTING BLOCKS
    • 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
      • 16.6.5.1 Detailed list of key startups/SMEs
      • 16.6.5.2 Competitive benchmarking of key startups
  • 16.7 BRAND/PRODUCT COMPARISON
  • 16.8 R&D EXPENDITURE OF KEY PLAYERS
  • 16.9 COMPANY VALUATION & FINANCIAL METRICS
    • 16.9.1 FINANCIAL METRICS
    • 16.9.2 COMPANY VALUATION
  • 16.10 COMPETITIVE SCENARIO
    • 16.10.1 PRODUCT LAUNCHES
    • 16.10.2 DEALS
    • 16.10.3 EXPANSIONS
    • 16.10.4 OTHER DEVELOPMENTS

17 COMPANY PROFILES

  • 17.1 KEY PLAYERS
    • 17.1.1 IDEXX LABORATORIES, INC.
      • 17.1.1.1 Business overview
      • 17.1.1.2 Products offered
      • 17.1.1.3 MnM view
        • 17.1.1.3.1 Key strengths
        • 17.1.1.3.2 Strategic choices
        • 17.1.1.3.3 Weaknesses & competitive threats
    • 17.1.2 THERMO FISHER SCIENTIFIC INC.
      • 17.1.2.1 Business overview
      • 17.1.2.2 Products offered
      • 17.1.2.3 MnM view
        • 17.1.2.3.1 Key strengths
        • 17.1.2.3.2 Strategic choices
        • 17.1.2.3.3 Weaknesses & competitive threats
    • 17.1.3 ZOETIS SERVICES LLC
      • 17.1.3.1 Business overview
      • 17.1.3.2 Products offered
      • 17.1.3.3 Recent developments
        • 17.1.3.3.1 Deals
        • 17.1.3.3.2 Expansions
        • 17.1.3.3.3 Other developments
      • 17.1.3.4 MnM view
        • 17.1.3.4.1 Key strengths
        • 17.1.3.4.2 Strategic choices
        • 17.1.3.4.3 Weaknesses & competitive threats
    • 17.1.4 BIOCHEK
      • 17.1.4.1 Business overview
      • 17.1.4.2 Products offered
      • 17.1.4.3 Recent developments
        • 17.1.4.3.1 Product launches
        • 17.1.4.3.2 Deals
      • 17.1.4.4 MnM view
        • 17.1.4.4.1 Key strengths
        • 17.1.4.4.2 Strategic choices
        • 17.1.4.4.3 Weaknesses & competitive threats
    • 17.1.5 INNOVATIVE DIAGNOSTICS
      • 17.1.5.1 Business overview
      • 17.1.5.2 Products offered
      • 17.1.5.3 Recent developments
        • 17.1.5.3.1 Other developments
      • 17.1.5.4 MnM view
        • 17.1.5.4.1 Key strengths
        • 17.1.5.4.2 Strategic choices
        • 17.1.5.4.3 Weaknesses & competitive threats
    • 17.1.6 BIONOTE
      • 17.1.6.1 Business overview
      • 17.1.6.2 Products offered
      • 17.1.6.3 Recent developments
        • 17.1.6.3.1 Deals
    • 17.1.7 BIO-RAD LABORATORIES, INC.
      • 17.1.7.1 Business overview
      • 17.1.7.2 Products offered
    • 17.1.8 GD
      • 17.1.8.1 Business overview
      • 17.1.8.2 Products offered
      • 17.1.8.3 Recent developments
        • 17.1.8.3.1 Product launches
        • 17.1.8.3.2 Deals
        • 17.1.8.3.3 Expansions
        • 17.1.8.3.4 Other developments
    • 17.1.9 INDICAL BIOSCIENCE GMBH
      • 17.1.9.1 Business overview
      • 17.1.9.2 Products offered
      • 17.1.9.3 Recent developments
        • 17.1.9.3.1 Product enhancements
    • 17.1.10 SHENZHEN BIOEASY BIOTECHNOLOGY, INC.
      • 17.1.10.1 Business overview
      • 17.1.10.2 Products offered
    • 17.1.11 RING BIOTECHNOLOGY CO., LTD.
      • 17.1.11.1 Business overview
      • 17.1.11.2 Products offered
      • 17.1.11.3 Recent developments
        • 17.1.11.3.1 Product launches
    • 17.1.12 BIO-X DIAGNOSTICS S.A.
      • 17.1.12.1 Business overview
      • 17.1.12.2 Products offered
    • 17.1.13 MEGACOR DIAGNOSTIK GMBH
      • 17.1.13.1 Business overview
      • 17.1.13.2 Products offered
    • 17.1.14 GOLD STANDARD DIAGNOSTICS
      • 17.1.14.1 Business overview
      • 17.1.14.2 Products offered
        • 17.1.14.2.1 Other developments
    • 17.1.15 BIONEER CORPORATION
      • 17.1.15.1 Business overview
      • 17.1.15.2 Products offered
  • 17.2 OTHER PLAYERS
    • 17.2.1 ELABSCIENCE, INC.
    • 17.2.2 BIOSELLAL
    • 17.2.3 BIOGAL
    • 17.2.4 BIOSTONE ANIMAL HEALTH
    • 17.2.5 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.
    • 17.2.6 ABBEXA
    • 17.2.7 BIOINGENTECH
    • 17.2.8 AFFIGEN INC.
    • 17.2.9 ALVEO TECHNOLOGIES
    • 17.2.10 HIMEDIA LABORATORIES

18 RESEARCH METHODOLOGY

  • 18.1 RESEARCH DATA
  • 18.2 RESEARCH METHODOLOGY DESIGN
    • 18.2.1 SECONDARY DATA
      • 18.2.1.1 Key data from secondary sources
    • 18.2.2 PRIMARY DATA
      • 18.2.2.1 Key data from primary sources
      • 18.2.2.2 Key industry insights
  • 18.3 MARKET SIZE ESTIMATION
    • 18.3.1 BOTTOM-UP APPROACH
  • 18.4 MARKET BREAKDOWN & DATA TRIANGULATION
  • 18.5 MARKET SHARE ANALYSIS
    • 18.5.1 RESEARCH ASSUMPTIONS
    • 18.5.2 GROWTH RATE ASSUMPTIONS
  • 18.6 RISK ASSESSMENT
  • 18.7 RESEARCH LIMITATIONS
    • 18.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 18.7.2 SCOPE-RELATED LIMITATIONS

19 APPENDIX

  • 19.1 DISCUSSION GUIDE
  • 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 19.3 CUSTOMIZATION OPTIONS
    • 19.3.1 PRODUCT ANALYSIS
    • 19.3.2 COMPANY INFORMATION
    • 19.3.3 GEOGRAPHIC ANALYSIS
    • 19.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
    • 19.3.5 COUNTRY-LEVEL VOLUME ANALYSIS, BY PRODUCT TYPE
    • 19.3.6 MARKET SHARE ANALYSIS, BY PRODUCT TYPE (TOP 5 PLAYERS)
    • 19.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
  • 19.4 RELATED REPORTS
  • 19.5 AUTHOR DETAILS
Show more
Product Code: MD 5241

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
  • TABLE 2 POULTRY DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 3 GDP CHANGE, BY KEY COUNTRY, 2021-2030 (USD BILLION)
  • TABLE 4 AVERAGE SELLING PRICE TREND OF POULTRY DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023-2025
  • TABLE 5 AVERAGE SELLING PRICE TREND OF ELISA KITS & REAGENTS, BY REGION, 2023-2025
  • TABLE 6 AVERAGE SELLING PRICE TREND OF PCR REAGENTS & KITS, BY REGION, 2023-2025
  • TABLE 7 AVERAGE SELLING PRICE TREND OF SAMPLE PREPARATION & EXTRACTION KITS, BY REGION, 2023-2025
  • TABLE 8 AVERAGE SELLING PRICE TREND OF CONTROLS & LABORATORY CONSUMABLES, BY REGION, 2023-2025
  • TABLE 9 AVERAGE SELLING PRICE TREND OF PCR INSTRUMENTS, BY REGION, 2023-2025
  • TABLE 10 AVERAGE SELLING PRICE TREND OF ELISA READERS & WASHERS, BY REGION, 2023-2025
  • TABLE 11 AVERAGE SELLING PRICE TREND OF NUCLEIC ACID EXTRACTION SYSTEMS, BY REGION, 2023-2025
  • TABLE 12 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 13 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021-2025 (USD THOUSAND)
  • TABLE 14 POULTRY DIAGNOSTICS MARKET: MAJOR CONFERENCES & EVENTS IN 2026-2027
  • TABLE 15 CASE STUDY 1: AI-POWERED POULTRY DISEASE DIAGNOSTICS FOR COCCIDIOSIS & SALMONELLA DETECTION
  • TABLE 16 CASE STUDY 2: MOLECULAR DETECTION AND CHARACTERIZATION OF AVIAN PATHOGENS USING MULTIPLEX PCR
  • TABLE 17 CASE STUDY 3: MULTIPLEX PCR DETECTION OF RESPIRATORY PATHOGENS IN COMMERCIAL POULTRY FLOCKS
  • TABLE 18 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 19 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR POULTRY DIAGNOSTIC PRODUCTS
  • TABLE 20 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
  • TABLE 21 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
  • TABLE 22 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
  • TABLE 23 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
  • TABLE 24 POULTRY DIAGNOSTICS MARKET: MAJOR PATENTS
  • TABLE 25 KEY COMPANIES IMPLEMENTING AI IN POULTRY DIAGNOSTICS MARKET
  • TABLE 26 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 27 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 28 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 29 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR POULTRY DIAGNOSTIC PRODUCTS
  • TABLE 30 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 31 POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 32 POULTRY DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 33 KEY PLAYERS PROVIDING CONSUMABLES & REAGENTS
  • TABLE 34 POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 35 POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 36 KEY PLAYERS PROVIDING ELISA KITS & REAGENTS
  • TABLE 37 POULTRY DIAGNOSTICS MARKET FOR ELISA KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 38 POULTRY DIAGNOSTICS MARKET FOR ELISA KITS & REAGENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 39 KEY PLAYERS PROVIDING PCR KITS & REAGENTS
  • TABLE 40 POULTRY DIAGNOSTICS MARKET FOR PCR KITS & REAGENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 41 POULTRY DIAGNOSTICS MARKET FOR PCR KITS & REAGENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 42 KEY PLAYERS PROVIDING SAMPLE PREPARATION & EXTRACTION KITS
  • TABLE 43 POULTRY DIAGNOSTICS MARKET FOR SAMPLE PREPARATION & EXTRACTION KITS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 44 POULTRY DIAGNOSTICS MARKET FOR SAMPLE PREPARATION & EXTRACTION KITS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 45 KEY PLAYERS PROVIDING CONTROLS & LABORATORY CONSUMABLES
  • TABLE 46 POULTRY DIAGNOSTICS MARKET FOR CONTROLS & LABORATORY CONSUMABLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 47 POULTRY DIAGNOSTICS MARKET FOR CONTROLS & LABORATORY CONSUMABLES, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 48 KEY PLAYERS PROVIDING INSTRUMENTS
  • TABLE 49 POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 50 POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 51 KEY PLAYERS PROVIDING PCR INSTRUMENTS
  • TABLE 52 POULTRY DIAGNOSTICS MARKET FOR PCR INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 53 POULTRY DIAGNOSTICS MARKET FOR PCR INSTRUMENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 54 KEY PLAYERS PROVIDING ELISA READERS & WASHERS
  • TABLE 55 POULTRY DIAGNOSTICS MARKET FOR ELISA READERS & WASHERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 56 POULTRY DIAGNOSTICS MARKET FOR ELISA READERS & WASHERS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 57 KEY PLAYERS PROVIDING NUCLEIC ACID EXTRACTION SYSTEMS
  • TABLE 58 POULTRY DIAGNOSTICS MARKET FOR NUCLEIC ACID EXTRACTION SYSTEMS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 59 POULTRY DIAGNOSTICS MARKET FOR NUCLEIC ACID EXTRACTION SYSTEMS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 60 POULTRY DIAGNOSTICS MARKET FOR OTHER LABORATORY AUTOMATION INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 61 POULTRY DIAGNOSTICS MARKET FOR OTHER LABORATORY AUTOMATION INSTRUMENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 62 POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 63 KEY PLAYERS PROVIDING PCR-BASED DIAGNOSTICS
  • TABLE 64 POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 65 POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 66 KEY PLAYERS PROVIDING AVIAN INFLUENZA PCR PANELS
  • TABLE 67 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA PCR PANELS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 68 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA PCR PANELS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 69 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA PCR PANELS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 70 KEY PLAYERS PROVIDING NEWCASTLE DISEASE PCR PANELS
  • TABLE 71 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE PCR PANELS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 72 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE PCR PANELS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 73 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE PCR PANELS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 74 KEY PLAYERS PROVIDING ENDEMIC VIRAL PCR PANELS
  • TABLE 75 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL PCR PANELS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 76 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL PCR PANELS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 77 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL PCR PANELS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 78 KEY PLAYERS PROVIDING MYCOPLASMA PCR PANELS
  • TABLE 79 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA PCR PANELS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 80 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA PCR PANELS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 81 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA PCR PANELS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 82 KEY PLAYERS PROVIDING BACTERIAL PCR PANELS
  • TABLE 83 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL PCR PANELS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 84 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL PCR PANELS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 85 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL PCR PANELS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 86 KEY PLAYERS PROVIDING ELISA-BASED DIAGNOSTICS
  • TABLE 87 POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 88 POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 89 KEY PLAYERS PROVIDING ENDEMIC VIRAL ELISA TESTS
  • TABLE 90 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL ELISA TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 91 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL ELISA TESTS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 92 POULTRY DIAGNOSTICS MARKET FOR ENDEMIC VIRAL ELISA TESTS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 93 KEY PLAYERS PROVIDING AVIAN INFLUENZA ELISA TESTS
  • TABLE 94 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA ELISA TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 95 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA ELISA TESTS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 96 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA ELISA TESTS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 97 KEY PLAYERS PROVIDING NEWCASTLE DISEASE ELISA TESTS
  • TABLE 98 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE ELISA TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 99 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE ELISA TESTS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 100 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE ELISA TESTS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 101 KEY PLAYERS PROVIDING MYCOPLASMA ELISA TESTS
  • TABLE 102 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA ELISA TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 103 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA ELISA TESTS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 104 POULTRY DIAGNOSTICS MARKET FOR MYCOPLASMA ELISA TESTS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 105 KEY PLAYERS PROVIDING BACTERIAL ELISA TESTS
  • TABLE 106 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL ELISA TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 107 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL ELISA TESTS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 108 POULTRY DIAGNOSTICS MARKET FOR BACTERIAL ELISA TESTS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 109 KEY PLAYERS PROVIDING OTHER DIAGNOSTIC TESTS
  • TABLE 110 POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 111 POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 112 KEY PLAYERS PROVIDING AVIAN INFLUENZA DIAGNOSTIC PRODUCTS
  • TABLE 113 POULTRY DIAGNOSTICS MARKET FOR AVIAN INFLUENZA, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 114 KEY PLAYERS PROVIDING NEWCASTLE DISEASE DIAGNOSTIC PRODUCTS
  • TABLE 115 POULTRY DIAGNOSTICS MARKET FOR NEWCASTLE DISEASE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 116 KEY PLAYERS PROVIDING INFECTIOUS BRONCHITIS DIAGNOSTIC PRODUCTS
  • TABLE 117 POULTRY DIAGNOSTICS MARKET FOR INFECTIOUS BRONCHITIS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 118 KEY PLAYERS PROVIDING AVIAN MYCOPLASMOSIS DIAGNOSTIC PRODUCTS
  • TABLE 119 POULTRY DIAGNOSTICS MARKET FOR AVIAN MYCOPLASMOSIS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 120 KEY PLAYERS PROVIDING SALMONELLOSIS DIAGNOSTIC PRODUCTS
  • TABLE 121 POULTRY DIAGNOSTICS MARKET FOR SALMONELLOSIS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 122 KEY PLAYERS PROVIDING INFECTIOUS BURSAL DISEASE DIAGNOSTIC PRODUCTS
  • TABLE 123 POULTRY DIAGNOSTICS MARKET FOR INFECTIOUS BURSAL DISEASE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 124 KEY PLAYERS PROVIDING OTHER INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS
  • TABLE 125 POULTRY DIAGNOSTICS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 126 POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 127 PCR-BASED DIAGNOSTICS MARKET FOR BROILERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 128 PCR-BASED DIAGNOSTICS MARKET FOR LAYERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 129 PCR-BASED DIAGNOSTICS MARKET FOR BREEDERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 130 PCR-BASED DIAGNOSTICS MARKET FOR TURKEYS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 131 PCR-BASED DIAGNOSTICS MARKET FOR DUCKS & GEESE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 132 PCR-BASED DIAGNOSTICS MARKET FOR OTHER POULTRY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 133 POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 134 ELISA-BASED DIAGNOSTICS MARKET FOR BROILERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 135 ELISA-BASED DIAGNOSTICS MARKET FOR LAYERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 136 ELISA-BASED DIAGNOSTICS MARKET FOR BREEDERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 137 ELISA-BASED DIAGNOSTICS MARKET FOR TURKEYS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 138 ELISA-BASED DIAGNOSTICS MARKET FOR DUCKS & GEESE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 139 ELISA-BASED DIAGNOSTICS MARKET FOR OTHER POULTRY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 140 POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 141 OTHER DIAGNOSTIC TESTS MARKET FOR BROILERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 142 OTHER DIAGNOSTIC TESTS MARKET FOR LAYERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 143 OTHER DIAGNOSTIC TESTS MARKET FOR BREEDERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 144 OTHER DIAGNOSTIC TESTS MARKET FOR TURKEYS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 145 OTHER DIAGNOSTIC TESTS MARKET FOR DUCKS & GEESE, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 146 OTHER DIAGNOSTIC TESTS MARKET FOR OTHER POULTRY, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 147 POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 148 POULTRY DIAGNOSTICS MARKET FOR SWABS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 149 POULTRY DIAGNOSTICS MARKET FOR SERUM/BLOOD, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 150 POULTRY DIAGNOSTICS MARKET FOR TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 151 POULTRY DIAGNOSTICS MARKET FOR ENVIRONMENTAL & FECAL SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 152 POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 153 POULTRY DIAGNOSTICS MARKET FOR VETERINARY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 154 POULTRY DIAGNOSTICS MARKET FOR INTEGRATED POULTRY PRODUCERS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 155 POULTRY DIAGNOSTICS MARKET FOR GOVERNMENT & REFERENCE LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 156 POULTRY DIAGNOSTICS MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 157 POULTRY DIAGNOSTICS MARKET FOR OTHER SPECIALIZED LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 158 POULTRY DIAGNOSTICS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 159 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 160 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 161 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 162 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 163 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 164 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 165 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 166 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 167 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 168 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 169 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 170 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 171 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 172 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 173 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 174 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 175 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 176 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 177 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 178 US: KEY MACROINDICATORS
  • TABLE 179 US: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 180 US: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 181 US: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 182 US: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 183 US: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 184 US: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 185 US: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 186 US: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 187 US: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 188 US: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 189 US: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 190 US: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 191 CANADA: KEY MACROINDICATORS
  • TABLE 192 CANADA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 193 CANADA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 194 CANADA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 195 CANADA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 196 CANADA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 197 CANADA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 198 CANADA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 199 CANADA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 200 CANADA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 201 CANADA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 202 CANADA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 203 CANADA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 204 EUROPE: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 205 EUROPE: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 206 EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 207 EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 208 EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 209 EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 210 EUROPE: POULTRY DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 211 EUROPE: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 212 EUROPE: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 213 EUROPE: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 214 EUROPE: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 215 EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 216 EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 217 EUROPE: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 218 EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 219 EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 220 EUROPE: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 221 EUROPE: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 222 EUROPE: POULTRY DIAGNOSTICS MARKET, BY END USER,

024-2031 (USD MILLION)

  • TABLE 223 GERMANY: KEY MACROINDICATORS
  • TABLE 224 GERMANY: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 225 GERMANY: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 226 GERMANY: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 227 GERMANY: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 228 GERMANY: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 229 GERMANY: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 230 GERMANY: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 231 GERMANY: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 232 GERMANY: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 233 GERMANY: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 234 GERMANY: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 235 GERMANY: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 236 UK: KEY MACROINDICATORS
  • TABLE 237 UK: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 238 UK: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 239 UK: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 240 UK: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 241 UK: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 242 UK: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 243 UK: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 244 UK: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 245 UK: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 246 UK: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 247 UK: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 248 UK: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 249 FRANCE: KEY MACROINDICATORS
  • TABLE 250 FRANCE: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 251 FRANCE: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 252 FRANCE: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 253 FRANCE: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 254 FRANCE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 255 FRANCE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 256 FRANCE: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 257 FRANCE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 258 FRANCE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 259 FRANCE: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 260 FRANCE: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 261 FRANCE: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 262 ITALY: KEY MACROINDICATORS
  • TABLE 263 ITALY: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 264 ITALY: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 265 ITALY: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 266 ITALY: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 267 ITALY: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 268 ITALY: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 269 ITALY: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 270 ITALY: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 271 ITALY: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 272 ITALY: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 273 ITALY: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 274 ITALY: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 275 SPAIN: KEY MACROINDICATORS
  • TABLE 276 SPAIN: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 277 SPAIN: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 278 SPAIN: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 279 SPAIN: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 280 SPAIN: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 281 SPAIN: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 282 SPAIN: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 283 SPAIN: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 284 SPAIN: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 285 SPAIN: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 286 SPAIN: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 287 SPAIN: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 288 NETHERLANDS: KEY MACROINDICATORS
  • TABLE 289 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 290 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 291 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 292 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 293 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 294 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 295 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 296 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 297 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 298 NETHERLANDS: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 299 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 300 NETHERLANDS: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 301 POLAND: KEY MACROINDICATORS
  • TABLE 302 POLAND: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 303 POLAND: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 304 POLAND: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 305 POLAND: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 306 POLAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 307 POLAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 308 POLAND: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 309 POLAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 310 POLAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 311 POLAND: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 312 POLAND: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 313 POLAND: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 314 RUSSIA: KEY MACROINDICATORS
  • TABLE 315 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 316 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 317 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 318 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 319 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 320 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 321 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 322 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 323 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 324 RUSSIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 325 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 326 RUSSIA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 327 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 328 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 329 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 330 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 331 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 332 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 333 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 334 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 335 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 336 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 337 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 338 REST OF EUROPE: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 339 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 340 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 341 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 342 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 343 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 344 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 345 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 346 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 347 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 348 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 349 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 350 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 351 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 352 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 353 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 354 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 355 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 356 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 357 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 358 CHINA: KEY MACROINDICATORS
  • TABLE 359 CHINA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 360 CHINA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 361 CHINA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 362 CHINA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 363 CHINA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 364 CHINA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 365 CHINA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 366 CHINA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 367 CHINA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 368 CHINA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 369 CHINA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 370 CHINA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 371 JAPAN: KEY MACROINDICATORS
  • TABLE 372 JAPAN: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 373 JAPAN: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 374 JAPAN: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 375 JAPAN: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 376 JAPAN: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 377 JAPAN: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 378 JAPAN: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 379 JAPAN: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 380 JAPAN: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 381 JAPAN: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 382 JAPAN: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 383 JAPAN: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 384 INDIA: KEY MACROINDICATORS
  • TABLE 385 INDIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 386 INDIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 387 INDIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 388 INDIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 389 INDIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 390 INDIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 391 INDIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 392 INDIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 393 INDIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 394 INDIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 395 INDIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 396 INDIA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 397 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 398 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 399 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 400 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 401 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 402 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 403 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 404 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 405 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 406 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 407 AUSTRALIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 408 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 409 AUSTRALIA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 410 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 411 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 412 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 413 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 414 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 415 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 416 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 417 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 418 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 419 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 420 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 421 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 422 SOUTH KOREA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 423 THAILAND: KEY MACROINDICATORS
  • TABLE 424 THAILAND: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 425 THAILAND: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 426 THAILAND: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 427 THAILAND: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 428 THAILAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 429 THAILAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 430 THAILAND: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 431 THAILAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 432 THAILAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 433 THAILAND: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 434 THAILAND: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 435 THAILAND: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 436 NEW ZEALAND: KEY MACROINDICATORS
  • TABLE 437 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 438 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 439 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 440 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 441 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 442 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 443 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 444 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 445 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 446 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 447 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 448 NEW ZEALAND: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 449 INDONESIA: KEY MACROINDICATORS
  • TABLE 450 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 451 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 452 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 453 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 454 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 455 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 456 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 457 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 458 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 459 INDONESIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 460 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 461 INDONESIA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 462 PHILIPPINES: KEY MACROINDICATORS
  • TABLE 463 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 464 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 465 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 466 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 467 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 468 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 469 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 470 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 471 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 472 PHILIPPINES: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 473 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 474 PHILIPPINES: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 475 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 476 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 477 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 478 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 479 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 480 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 481 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 482 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 483 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 484 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 485 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 486 REST OF ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 487 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 488 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 489 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 490 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 491 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 492 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 493 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 494 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 495 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 496 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 497 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 498 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 499 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 500 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 501 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 502 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 503 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 504 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 505 LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 506 BRAZIL: KEY MACROINDICATORS
  • TABLE 507 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 508 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 509 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 510 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 511 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 512 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 513 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 514 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 515 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 516 BRAZIL: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 517 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 518 BRAZIL: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 519 MEXICO: KEY MACROINDICATORS
  • TABLE 520 MEXICO: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 521 MEXICO: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 522 MEXICO: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 523 MEXICO: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 524 MEXICO: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 525 MEXICO: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 526 MEXICO: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 527 MEXICO: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 528 MEXICO: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 529 MEXICO: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 530 MEXICO: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 531 MEXICO: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 532 ARGENTINA: KEY MACROINDICATORS
  • TABLE 533 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 534 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 535 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 536 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 537 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 538 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 539 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 540 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 541 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 542 ARGENTINA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 543 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 544 ARGENTINA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 545 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 546 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 547 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 548 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 549 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 550 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 551 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 552 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 553 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 554 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 555 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 556 REST OF LATIN AMERICA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 557 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 558 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (THOUSAND UNITS)
  • TABLE 559 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 560 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 561 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND TESTS)
  • TABLE 562 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (THOUSAND ANIMALS)
  • TABLE 563 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 564 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 565 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 566 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 567 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 568 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 569 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 570 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 571 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 572 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 573 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 574 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 575 MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 576 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 577 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 578 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 579 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 580 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 581 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 582 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 583 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 584 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 585 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 586 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 587 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 588 GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 589 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS
  • TABLE 590 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 591 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 592 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 593 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 594 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 595 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 596 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 597 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 598 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 599 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 600 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 601 KINGDOM OF SAUDI ARABIA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 602 UNITED ARAB EMIRATES: KEY MACROINDICATORS
  • TABLE 603 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 604 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 605 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 606 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 607 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 608 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 609 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 610 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 611 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 612 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 613 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 614 UNITED ARAB EMIRATES: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 615 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 616 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 617 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 618 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 619 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 620 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 621 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 622 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 623 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 624 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 625 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 626 REST OF GCC COUNTRIES: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 627 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
  • TABLE 628 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR CONSUMABLES & REAGENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 629 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR INSTRUMENTS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 630 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY TEST TYPE, 2024-2031 (USD MILLION)
  • TABLE 631 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 632 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY TYPE, 2024-2031 (USD MILLION)
  • TABLE 633 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE, 2024-2031 (USD MILLION)
  • TABLE 634 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR PCR-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 635 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR ELISA-BASED DIAGNOSTICS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 636 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET FOR OTHER DIAGNOSTIC TESTS, BY POULTRY TYPE, 2024-2031 (USD MILLION)
  • TABLE 637 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
  • TABLE 638 REST OF MIDDLE EAST & AFRICA: POULTRY DIAGNOSTICS MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 639 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET
  • TABLE 640 POULTRY DIAGNOSTICS MARKET: DEGREE OF COMPETITION
  • TABLE 641 US POULTRY DIAGNOSTICS MARKET: DEGREE OF COMPETITION
  • TABLE 642 EUROPE POULTRY DIAGNOSTICS MARKET: DEGREE OF COMPETITION
  • TABLE 643 POULTRY DIAGNOSTICS MARKET: REGION FOOTPRINT
  • TABLE 644 POULTRY DIAGNOSTICS MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 645 POULTRY DIAGNOSTICS MARKET: TEST TYPE FOOTPRINT
  • TABLE 646 POULTRY DIAGNOSTICS MARKET: DISEASE TYPE FOOTPRINT
  • TABLE 647 POULTRY DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 648 POULTRY DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS
  • TABLE 649 POULTRY DIAGNOSTICS MARKET: PRODUCT LAUNCHES, JANUARY 2022-FEBRUARY 2026
  • TABLE 650 POULTRY DIAGNOSTICS MARKET: DEALS, JANUARY 2022-FEBRUARY 2026
  • TABLE 651 POULTRY DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2022-FEBRUARY 2026
  • TABLE 652 POULTRY DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022-FEBRUARY 2026
  • TABLE 653 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 654 IDEXX LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 655 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 656 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 657 ZOETIS SERVICES LLC: COMPANY OVERVIEW
  • TABLE 658 ZOETIS SERVICES LLC: PRODUCTS OFFERED
  • TABLE 659 ZOETIS SERVICES LLC: DEALS, JANUARY 2022-FEBRUARY 2026
  • TABLE 660 ZOETIS SERVICES LLC: EXPANSIONS, JANUARY 2022-FEBRUARY 2026
  • TABLE 661 ZOETIS SERVICES LLC: OTHER DEVELOPMENTS, JANUARY 2022-FEBRUARY 2026
  • TABLE 662 BIOCHEK: COMPANY OVERVIEW
  • TABLE 663 BIOCHEK: PRODUCTS OFFERED
  • TABLE 664 BIOCHEK: PRODUCT LAUNCHES, JANUARY 2022-FEBRUARY 2026
  • TABLE 665 BIOCHEK: DEALS, JANUARY 2022-FEBRUARY 2026
  • TABLE 666 INNOVATIVE DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 667 INNOVATIVE DIAGNOSTICS: PRODUCTS OFFERED
  • TABLE 668 INNOVATIVE DIAGNOSTICS: OTHER DEVELOPMENTS, JANUARY 2022-FEBRUARY 2026
  • TABLE 669 BIONOTE: COMPANY OVERVIEW
  • TABLE 670 BIONOTE: PRODUCTS OFFERED
  • TABLE 671 BIONOTE: DEALS, JANUARY 2022-FEBRUARY 2026
  • TABLE 672 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 673 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 674 GD: COMPANY OVERVIEW
  • TABLE 675 GD: PRODUCTS OFFERED
  • TABLE 676 GD: PRODUCT LAUNCHES, JANUARY 2022-FEBRUARY 2026
  • TABLE 677 GD: DEALS, JANUARY 2022-FEBRUARY 2026
  • TABLE 678 GD: EXPANSIONS, JANUARY 2022-FEBRUARY 2026
  • TABLE 679 GD: OTHER DEVELOPMENTS, JANUARY 2022-FEBRUARY 2026
  • TABLE 680 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW
  • TABLE 681 INDICAL BIOSCIENCE GMBH: PRODUCTS OFFERED
  • TABLE 682 INDICAL BIOSCIENCE GMBH: PRODUCT ENHANCEMENTS, JANUARY 2022-FEBRUARY 2026
  • TABLE 683 SHENZHEN BIOEASY BIOTECHNOLOGY, INC: COMPANY OVERVIEW
  • TABLE 684 SHENZHEN BIOEASY BIOTECHNOLOGY, INC: PRODUCTS OFFERED
  • TABLE 685 RING BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 686 RING BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED
  • TABLE 687 RING BIOTECHNOLOGY CO., LTD.: PRODUCT LAUNCHES, JANUARY 2022-FEBRUARY 2026
  • TABLE 688 BIO-X DIAGNOSTICS S.A.: COMPANY OVERVIEW
  • TABLE 689 BIO-X DIAGNOSTICS S.A.: PRODUCTS OFFERED
  • TABLE 690 MEGACOR DIAGNOSTIK GMBH: COMPANY OVERVIEW
  • TABLE 691 MEGACOR DIAGNOSTIK GMBH: PRODUCTS OFFERED
  • TABLE 692 GOLD STANDARD DIAGNOSTICS: COMPANY OVERVIEW
  • TABLE 693 GOLD STANDARD DIAGNOSTICS: PRODUCTS OFFERED
  • TABLE 694 GOLD STANDARD DIAGNOSTICS: OTHER DEVELOPMENTS, JANUARY 2022-FEBRUARY 2026
  • TABLE 695 BIONEER CORPORATION: COMPANY OVERVIEW
  • TABLE 696 BIONEER CORPORATION: PRODUCTS OFFERED
  • TABLE 697 ELABSCIENCE, INC.: COMPANY OVERVIEW
  • TABLE 698 BIOSELLAL: COMPANY OVERVIEW
  • TABLE 699 BIOGAL: COMPANY OVERVIEW
  • TABLE 700 BIOSTONE ANIMAL HEALTH: COMPANY OVERVIEW
  • TABLE 701 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.: COMPANY OVERVIEW
  • TABLE 702 ABBEXA: COMPANY OVERVIEW
  • TABLE 703 BIOINGENTECH: COMPANY OVERVIEW
  • TABLE 704 AFFIGEN INC.: COMPANY OVERVIEW
  • TABLE 705 ALVEO TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 706 HIMEDIA LABORATORIES: COMPANY OVERVIEW
  • TABLE 707 RISK ASSESSMENT ANALYSIS

List of Figures

  • FIGURE 1 POULTRY DIAGNOSTICS MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 MARKET SCENARIO
  • FIGURE 3 GLOBAL POULTRY DIAGNOSTICS MARKET, 2024-2031
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET, 2020-2025
  • FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF POULTRY DIAGNOSTICS MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS IN POULTRY DIAGNOSTICS MARKET, 2026-2031
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN POULTRY DIAGNOSTICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
  • FIGURE 8 INCREASING POULTRY DISEASE SURVEILLANCE TO FUEL MARKET GROWTH
  • FIGURE 9 CONSUMABLES & REAGENTS SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
  • FIGURE 10 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 13 POULTRY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14 POULTRY DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 15 POULTRY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 16 POULTRY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 17 POULTRY DIAGNOSTICS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 18 AVERAGE SELLING PRICE OF POULTRY DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2025
  • FIGURE 19 AVERAGE SELLING PRICE OF ELISA KITS AND REAGENTS AND PCR REAGENTS AND KITS, BY REGION, 2025
  • FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 21 POULTRY DIAGNOSTICS MARKET: INVESTMENT & FUNDING SCENARIO
  • FIGURE 22 POULTRY DIAGNOSTICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2015-FEBRUARY 2026)
  • FIGURE 23 TOP APPLICANT COUNTRIES/REGIONS FOR POULTRY DIAGNOSTIC PATENTS (JANUARY 2015-FEBRUARY 2026)
  • FIGURE 24 AI USE CASES
  • FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR POULTRY DIAGNOSTIC PRODUCTS
  • FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 27 POULTRY DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 28 NORTH AMERICA: POULTRY DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 29 ASIA PACIFIC: POULTRY DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET (2021-2025)
  • FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET (2025)
  • FIGURE 32 US MARKET SHARE ANALYSIS OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET (2025)
  • FIGURE 33 EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET (2025)
  • FIGURE 34 RANKING OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET, 2025
  • FIGURE 35 POULTRY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 36 POULTRY DIAGNOSTICS MARKET: COMPANY FOOTPRINT
  • FIGURE 37 POULTRY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 38 POULTRY DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 39 R&D EXPENDITURE OF KEY PLAYERS IN POULTRY DIAGNOSTICS MARKET, 2022-2025
  • FIGURE 40 EV/EBITDA OF KEY VENDORS
  • FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 42 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 43 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 44 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2025)
  • FIGURE 45 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 46 BIONEER CORPORATION: COMPANY SNAPSHOT (2025)
  • FIGURE 47 POULTRY DIAGNOSTICS MARKET: RESEARCH DESIGN
  • FIGURE 48 PRIMARY SOURCES
  • FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
  • FIGURE 50 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
  • FIGURE 51 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 52 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 53 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
  • FIGURE 54 REVENUE ANALYSIS OF TOP FIVE COMPANIES: POULTRY DIAGNOSTICS MARKET (2025)
  • FIGURE 55 DEMAND-SIDE MARKET ESTIMATION FOR POULTRY DIAGNOSTIC CONSUMABLES & REAGENTS
  • FIGURE 56 DEMAND-SIDE MARKET ESTIMATION FOR POULTRY DIAGNOSTIC INSTRUMENTS
  • FIGURE 57 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF POULTRY DIAGNOSTICS MARKET (2026-2031)
  • FIGURE 58 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 59 TOP-DOWN APPROACH
  • FIGURE 60 BOTTOM-UP APPROACH
  • FIGURE 61 MARKET DATA TRIANGULATION METHODOLOGY
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!